Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of an Optimized Ibuprofen Dosing Regimen Versus Standard Dosing for Pharmacologic Closure of Patent Ductus Arteriosus

NCT00961753 is registered in ClinicalTrials.gov with OSF Healthcare System as lead sponsor.

NCT NCT00961753
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00961753 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of an Optimized Ibuprofen Dosing Regimen Versus Standard Dosing for Pharmacologic Closure of Patent Ductus Arteriosus
Lead sponsor
OSF Healthcare System
Phase
Phase 4
Overall status
Terminated
Start date
August 31, 2009
Completion date
October 31, 2010
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

patent ductus arteriosus